Seattle, WA, United States of America

Kyle Langford

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Phase Genomics Inc.. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Kyle Langford

Introduction

Kyle Langford is an accomplished inventor based in Seattle, WA. He has made significant strides in the field of biotechnology, particularly in the area of DNA sequencing. His work has the potential to advance our understanding of genetic material and its applications in various scientific fields.

Latest Patents

Kyle Langford holds a patent for a "Method for the clustering of DNA sequences." This patent describes methods and compositions for performing in vivo proximity-ligation in combination with DNA capture technology. The innovation allows for the cross-linking of physically adjacent DNA sequences within a mixed population of cells, enabling the isolation of cross-linked DNA junctions where at least one DNA sequence of interest is present. This patent represents a significant advancement in genetic research and has the potential to impact various applications in genomics.

Career Highlights

Kyle is currently employed at Phase Genomics Inc., a company that focuses on innovative genomic technologies. His role at the company allows him to apply his expertise in DNA sequencing and contribute to groundbreaking research in the field.

Collaborations

Kyle collaborates with notable colleagues, including Ivan Liachko and Shawn Thomas Sullivan. These partnerships enhance the research environment and foster innovation within the company.

Conclusion

Kyle Langford's contributions to the field of biotechnology, particularly through his patent on DNA sequencing methods, highlight his role as a leading inventor in this area. His work at Phase Genomics Inc. and collaborations with esteemed colleagues further underscore his impact on scientific advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…